Skip to main content

Aptevo Therapeutics Inc 8-K, filed Nov 2, 2026

Aptevo Therapeutics Inc. (APVO)

8-K 2026-11-02 For: 2026-10-30
View Original
Added on November 03, 2026

About this 8-K

Aptevo Therapeutics Inc filed this 8-K on November 2, 2026, reporting on events of October 30, 2026.

Aptevo filed a prospectus supplement for up to $2,309,834 of common stock sales under its existing at-the-market agreement with Roth Capital Partners. Previously it sold 303,157 shares for $11.8 million gross proceeds. AI summary

Items reported

  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits